J Clin Neurol.  2017 Apr;13(2):203-204. 10.3988/jcn.2017.13.2.203.

Evolution of Neurolymphomatosis to Lymphomatosis Cerebri

• Chang GY

• KMID: 2376025
• DOI: http://doi.org/10.3988/jcn.2017.13.2.203

Abstract

No abstract available.

MeSH Terms

Animals
Marek Disease*

Figure

• 

  Fig. 1 Gadolinium-enhanced T1-weighted coronal slices (A and B) at the initial presentation, revealing enhancement of the right temporal gyrus (A, arrow) and the ipsilateral maxillary branch of trigeminal nerve (B, arrow). Axial T2-weighted slice (C) demonstrating no apparent parenchymal signal change. Three months later, T2-weighted axial slice (D) reveal bilateral signal changes without obvious edema. Gadolinium-enhanced T1-weighted sequence reveals subtle enhancement of the medial lenticular nuclei (E). The previously prominent cranial nerve and temporal gyral lesion enhancement were nearly resolved (not shown).

Reference

1. Gerstner ER, Batchelor TT. Primary central nervous system lymphoma. Arch Neurol. 2010; 67:291–297.

2. Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015; 523:337–341.

3. Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol. 2011; 32:984–992.

4. Kitai R, Hashimoto N, Yamate K, Ikawa M, Yoneda M, Nakajima T, et al. Lymphomatosis cerebri: clinical characteristics, neuroimaging, and pathological findings. Brain Tumor Pathol. 2012; 29:47–53.

5. Taylor JW, Flanagan EP, O'Neill BP, Siegal T, Omuro A, Deangelis L, et al. Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report. Neurology. 2013; 81:1690–1696.